Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MBC.0000000000000199PMID 25325344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS

  2013cited by this paper
• Platelet oxidative stress and thrombosis.

  2012cited by this paper
• Diabetes mellitus and thrombosis.

  2012cited by this paper
• Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy

  2012cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective

  2011cited by this paper
• Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.

  2011cited by this paper
• Effect of Cigarette Smoking on Platelet Aggregation

  2011cited by this paper
• Aspirin resistance: effect of clinical, biochemical and genetic factors.

  2011cited by this paper
• Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans

  2010cited by this paper
• Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

  2010cited by this paper
• Clinical relevance of microparticles from platelets and megakaryocytes

  2010cited by this paper
• Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.

  2009cited by this paper
• Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin

  2009cited by this paper
• Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

  2009cited by this paper
• Pharmacogenetics in cardiovascular antithrombotic therapy.

  2009cited by this paper
• Aspirin resistance associated with HbA1c and obesity in diabetic patients.

  2008cited by this paper
• The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid

  2008cited by this paper
• Function and role of microparticles in various clinical settings.

  2008cited by this paper
• Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.

  2008cited by this paper
• Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.

  2008cited by this paper
• Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses

  2008cited by this paper
• Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• Determination of the antioxidant status of plasma from type 2 diabetic patients.

  2007cited by this paper
• Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.

  2007cited by this paper
• Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel

  2007cited by this paper
• Aspirin resistance.

  2007cited by this paper
• Espécies reativas de oxigênio e de nitrogênio, antioxidantes e marcadores de dano oxidativo em sangue humano: principais métodos analíticos para sua determinação

  2007cited by this paper
• Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

  2006cited by this paper
• Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003).

  2006cited by this paper
• Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.

  2006cited by this paper
• Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels

  2005cited by this paper
• Aspirin sensitivity of platelet aggregation in diabetes mellitus.

  2005cited by this paper
• Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment.

  2005cited by this paper
• Glycoprotein IIIA Gene (PIA) Polymorphism and Aspirin Resistance: Is There Any Correlation?

  2005cited by this paper
• The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.

  2005cited by this paper
• Aspirin resistance

  2005cited by this paper
• Prevalence of aspirin resistance in patients with type 2 diabetes

  2005cited by this paper
• New horizons in the analysis of circulating cell-derived microparticles.

  2004cited by this paper
• Genetic variation in cyclooxygenase 1: Effects on response to aspirin

  2003cited by this paper
• Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.

  2000cited by this paper
• Effect of Low-Dose Aspirin on the Markers of Oxidative Stress

  1999cited by this paper
• Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects

  1998cited by this paper
• Quantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation.

  1995cited by this paper
• Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin.

  1995cited by this paper
• The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.

  1989cited by this paper

• Acetylsalicylic acid inhibition of the lipoxygenase pathway: implications for HIV prevention.

  2024cites this paper
• JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia

  2023cites this paper
• Effect of the use of Chia (Salvia Hispanica L.) seeds on antioxidant status and anthropometric parameters in obese, type 2 diabetics and/or hypertensive patients

  2022cites this paper
• Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia

  2022cites this paper
• The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms

  2021cites this paper
• Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients

  2021cites this paper
• PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes

  2021cites this paper
• Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran

  2020cites this paper
• Effect of acetylsalicylic acid intake on platelet derived microvesicles in healthy subjects

  2020influential citation
• Extracellular vesicle concentration and procoagulant activity of canine haemoperitoneum fluid and packed red blood cells.

  2019cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis

  2019cites this paper
• Association of platelet-derived microvesicles with high on-treatment platelet reactivity in convalescent ischemic stroke patients treated with acetylsalicylic acid

  2019cites this paper
• Antioxidant capacity of Typha angustifolia extracts and two active flavonoids

  2017cites this paper
• Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome

  2017cites this paper
• The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles

  2017cites this paper
• Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring - A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application.

  2017cites this paper
• Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy

  2016cites this paper
• El ácido acetilsalicílico reduce la liberación de micropartículas eritrocitarias, monocitarias y de células del músculo liso vascular en pacientes diabéticos

  2016cites this paper
• Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.

  2016influential citation
• A brief review on the mechanisms of aspirin resistance.

  2016cites this paper